Unlicensed Cannabis Association Faces Trial in Spanish City

Nov.24.2023
Unlicensed Cannabis Association Faces Trial in Spanish City
The cannabis association "Green Pharmacy" faces trial next Tuesday for allegedly selling and distributing marijuana without permission in Alhaurin, Spain.

A marijuana association called "Green Pharmacy" is facing charges for selling and distributing marijuana in the city of Arcos de la Frontera, Spain, without proper licenses and regulation. The case is scheduled to be heard in a provincial high court next Tuesday. The association's president, C.G, and secretary, N.J, have been accused by the prosecutor.


According to the prosecution, these two individuals have been illegally selling marijuana since April 1, 2016, until the association was shut down on February 7, 2019.


In addition, the association did not apply for a sales license from the Spanish Medicines and Healthcare Products Agency. Consequently, the prosecution highlights that this is a serious public health offense and illegal association crime.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Heno Biotech Releases 2024 ESG Report at Inter Tabac, Setting a New Global Benchmark for the Nicotine Industry Through Green Development and Compliance Governance
Heno Biotech Releases 2024 ESG Report at Inter Tabac, Setting a New Global Benchmark for the Nicotine Industry Through Green Development and Compliance Governance
At InterTabac, the world’s largest tobacco industry exhibition in Dortmund, Germany, Heno Biotech released its 2024 Environmental, Social, and Governance (ESG) Report. As a leading enterprise in China’s natural nicotine sector, Heno presented its third consecutive annual ESG disclosure, highlighting achievements in green development, compliance governance, and social responsibility, setting a new benchmark for sustainable growth in the industry.
Sep.18
Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male
Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male
Russia’s Chair of the State Duma Committee on Youth Policy warns that among 11–14-year-olds, girls now vape at higher rates than boys, a trend he calls “deeply concerning.” He says the spread of nicotine products—especially e-cigarettes—among minors poses a public health risk and warrants continued policy-level interventions.
Oct.17 by 2FIRSTS.ai
InterTabac 2025 Insights|Brands like NYSM and KIWI are promoting small-sized e-cigarettes, none of which feature screens
InterTabac 2025 Insights|Brands like NYSM and KIWI are promoting small-sized e-cigarettes, none of which feature screens
Inter Tabac 2025, held in Dortmund, Germany, took place from September 18th to 20th. 2Firsts observed that some booths, including those of NYSM, KIWI, Mevol, and FLERBAR, showcased small e-cigarettes. These devices were smaller or thinner than traditional disposable or cartridge-based e-cigarettes and lacked screen functionality.
Sep.23 by 2FIRSTS.ai
Thai Police Seize 48,000 Illegal E-Cigarettes Worth About $630,000
Thai Police Seize 48,000 Illegal E-Cigarettes Worth About $630,000
Acting on directives from senior government and police officials, Thai authorities seized 48,301 e-cigarettes and related products in central Thailand, valued at about 20 million baht (approximately US$630,000), as part of a crackdown on illegal vaping.
Oct.15 by 2FIRSTS.ai
UK Advocacy Groups Launch "20IsPlenty" Campaign for Nicotine Pouch Strength Limit of 20mg
UK Advocacy Groups Launch "20IsPlenty" Campaign for Nicotine Pouch Strength Limit of 20mg
UK harm reduction groups led by We Vape have launched the “20IsPlenty” campaign calling for a 20mg nicotine pouch cap, a ban on youth advertising, and evidence-based regulation. The initiative coincides with the Tobacco and Vapes Bill debate and aims to ensure pouches remain accessible as safer alternatives for smokers.
Oct.28 by 2FIRSTS.ai
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10